Achronix Announces 100G Ethernet Functionality Demonstration in Speedster22i 22nm FPGAs

Achronix Semiconductor Corporation today announced that it has demonstrated error-free operation of 100G Ethernet functionality using the hard Ethernet IP in its Speedster22i® FPGAs. Speedster22i are the only FPGAs that have hardened IP for communication applications including 100G Ethernet, 100G Interlaken, PCI Express Gen3 x8 and DDR3 memory controllers. The 100G Ethernet video demonstration can be seen at Achronix.com.

"The hardened IP functions in Speedster22i FPGAs translate directly into power and cost savings for high bandwidth communication applications," said Steve Mensor, vice president of Marketing at Achronix. "More importantly, the hardened IP functions eliminate the challenges associated with closing timing for these high performance applications."

Speedster22i FPGAs are built on Intel's advanced 22nm, 3-D Tri-Gate transistor technology. Speedster22i HD devices consume half the power and are half the cost of competitive high-end FPGAs for targeted high bandwidth applications. The 100G Ethernet was demonstrated on the HD1000 device, which has 1 million effective programmable look-up-tables (LUTs). The HD680 is the second member of the Speedster22i family and will begin shipping in Q1 2014.

About Achronix Semiconductor Corporation
Achronix is a privately held fabless corporation based in Santa Clara, California. Achronix builds application targeted field programmable gate arrays (FPGAs) built on Intel's (NASDAQ: INTC) 22nm, 3-D Tri-Gate transistor technology. Achronix ACE design tools include integrated support for Synopsys (NASDAQ: SNPS) Synplify Pro. Achronix has sales offices and representatives in the United States, Europe, and China, and has a research and design office in Bangalore, India.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.